|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/426 | (2006.01) |
| A61K 9/10 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61P 13/10 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3278801 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16773147.0 |
| Date of filing the European patent application | 2016-03-31 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation | 2020-01-10 |
| (86) | Number | PCT/JP2016/060745 |
| Date | 2016-03-31 |
| (87) | Number | WO 2016/159267 |
| Date | 2016-10-06 |
| (30) | Number | Date | Country code |
| 2015073911 | 2015-03-31 | JP |
| (72) |
TAKAE, Seiji, JP
SAKAI, Toshiro, JP
KASASHIMA, Yuki, JP
ANSEI, Yurina, JP
KIYOTA, Tsuyoshi, JP
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė kompozicija, turinti mirabegrono |
| PHARMACEUTICAL COMPOSITION CONTAINING MIRABEGRON |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 11 | 289.00 EUR |
| 2027-03-31 |